Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Health Sci Rep ; 4(3): e350, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34401526

ABSTRACT

BACKGROUND: Reapplication of sunscreen every 2 hours is recommended, especially after swimming, sweating, or working outdoors. However, the sustainability of sunscreen during the workday among outdoor workers is still unclear. OBJECTIVE: To evaluate the course of facial sunscreen coverage and sustainability over an 8-hour workday among outdoor workers. MATERIALS AND METHODS: This open-label trial included 20 healthy subjects who spend at least 80% of their workday outdoors. All volunteers applied 2 mg/cm2 of provided broad-spectrum sunscreen mixed with the invisible blue fluorescent agent to all parts of their face in the morning. A VISIA-CR camera was used to capture facial fluorescence intensity every 2 hours, and digital image analysis software was used to quantify fluorescence intensity at six areas of the face at each time point for 8 hours. RESULTS: Sunscreen coverage declined most rapidly during the first 2 hours with a mean reduction of 18.31%. By the end of the 8-hour study workday, the mean decrease in sunscreen coverage was 31.63% (range: 17.39%-45.29%). CONCLUSION: Reapplication of sunscreen is essential among outdoor workers. After 4 hours, the amount of sunscreen remaining on the face may not be sufficient for protecting the skin from harmful ultraviolet radiation.

2.
J Cosmet Dermatol ; 19(7): 1642-1647, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32384205

ABSTRACT

BACKGROUND: Postacne erythema (PAE) is a common sequela of inflammatory acne vulgaris, treatment of which has been challenging due to limited options available and the variability of results for each modality. Recently, a 577-nm high-power optically pumped semiconductor laser (HOPSL) initially developed for vascular lesions has shown promising results for the treatment of PAE. AIMS: To evaluate the efficacy and safety of 577-nm HOPSL in the treatment of postacne erythema. METHODS: This was a split-face, randomized controlled trial pilot study. Twenty-one patients with PAE on both sides of their face were enrolled. Each subject's face sides were randomly assigned to either receive 577-nm HOPSL treatment (QuadroStar PRO™, Asclepion Laser Technologies) using the scanner handpiece, 1mm spot size, 80% coverage, 12-15 J/cm2 , 30 ms, 2 passes for 3 sessions at 1-month intervals, or no treatment at all. Outcome measures such as overall improvement, the Erythema Index (EI), and Melanin Index (MI) from 3 different areas on both treatment and control sides were assessed at baseline, and 1-month follow-up after each treatment session. Side effects including pain, erythema, swelling, and crusting were also recorded. RESULTS: Upon completion of the treatment period, the mean EI was significantly decreased in both treated and nontreated sides of the face (P < .001 and P = .001, respectively). The laser-treated sides already demonstrated significant reduction in the mean EI compared with nontreated sides at 1 month after the 2nd treatment (P = .007). The mean MI of both sides, however, did not show any statistically significant differences from baseline, and likewise when comparing between sides. Patients reported more improvement on laser-treated sides compared with nontreated sides. Reported side effects were limited to mild discomfort during treatment and transient facial erythema lasting approximately 30 minutes. CONCLUSION: Patients who received treatment with the 577-nm HOPSL had better outcomes with minimal side effects at 1 month after 2 treatments as compared to those who did not receive any treatment. Therefore, the 577-nm HOPSL may be considered as an effective adjuvant treatment for PAE and early erythematous atrophic scars.


Subject(s)
Acne Vulgaris , Low-Level Light Therapy , Erythema/etiology , Humans , Lasers, Semiconductor/adverse effects , Pilot Projects , Treatment Outcome
3.
J Cosmet Dermatol ; 19(9): 2333-2338, 2020 Sep.
Article in English | MEDLINE | ID: mdl-31925917

ABSTRACT

BACKGROUND: Studies of the laser treatment of nondermatophyte mold (NDM) onychomycosis are limited. Long-pulsed neodymium:yttrium-aluminum-garnet (Nd:YAG) 1064-nm laser has been introduced as an adjuvant dermatophyte onychomycosis treatment. AIMS: To investigate the efficacy and safety of long-pulsed Nd:YAG 1064-nm laser for NDM onychomycosis treatment, compared with topical amorolfine nail lacquer alone and a combination treatment. PATIENTS/METHODS: This randomized controlled trial was conducted at the Nail Clinic, Siriraj Hospital. Patients diagnosed with NDM were included and randomly assigned to three treatment groups: laser at 1 month interval (1064-nm Nd:YAG at a fluence of 35 J/cm2 , pulse width 30 ms, and pulse rate 1.0 Hz); topical amorolfine nail lacquer alone; and a combination treatment. RESULTS: Sixty patients completed the study. The patients treated with the laser, amorolfine, and the combination achieved mycological cure rates of 35%, 60%, and 65%, respectively (P = .05), while 10%, 30%, and 30% of the patients in the respective groups were clinically cured. The mean durations to the mycological cures in the patients treated with laser, amorolfine, and the combination were 5.9, 4.8, and 5.2 months, respectively. By comparison, the corresponding mean durations to the clinical cures were 6.9, 6.5, and 5.9 months. Both the times to the mycological cures and the clinical cures did not differ significantly between the groups (P = .290 and P = .309, respectively). There were no serious complications with the laser treatment. CONCLUSIONS: Laser alone achieved only a 30% mycological cure rate for NDM onychomycosis. The combination treatment yielded similar outcomes to the topical treatment alone.


Subject(s)
Lasers, Solid-State , Onychomycosis , Aluminum , Antifungal Agents/therapeutic use , Humans , Lacquer , Morpholines , Neodymium , Onychomycosis/drug therapy , Treatment Outcome , Yttrium
4.
Indian Dermatol Online J ; 9(5): 314-317, 2018.
Article in English | MEDLINE | ID: mdl-30258798

ABSTRACT

BACKGROUND: Nail involvement in psoriasis is often complicated by concomitant fungal infections. The aim of this study was to investigate the prevalence of fungal infections in nail psoriasis and correlate it with the severity of nail psoriasis. MATERIALS AND METHODS: This retrospective study included patients with nail psoriasis aged ≥18 years with at least one fingernail and one toenail involvement who were treated at Siriraj Hospital from September 2012 to January 2014. Severity of nail psoriasis was assesed by Nail Psoriasis Area Severity Index (NAPSI) score. The nail clippings from the the least and most severely involved psoriatic fingernails and toenails were cultured to determine the presence of coexisting fungal infections and isolate the fungal species. RESULTS: Sixty-two patients (33 males, 29 females) fulfilling the inclusion criteria were included in the study. The mean age at the time of presentation was 51.3 years mention SD. The most common nail change consistent with psoriasis was onycholysis, followed by subungual hyperkeratosis. The most commonly isolated fungi in the most severely affected fingernails were Candida spp. (41.9%) manifesting as paronychia in 5 patients (19.2%). The most commonly isolated fungi in the most severely affected toenails were nondermatophytes (NDMs) other than candida (32.3%). Dermatophytes were not detected from any of the psoriatic nails. The fungal species isolated from the most severely affected fingernails were significantly different than the isolated fungal species in the most severely affected toenails (P = 0.026). Fungal organisms were identified in 32.3% of the most severely affected fingernails and in 27.4% of the most severely affected toenails. The overall rate of isolation of fungus was significantly significantly higher in severely affected nails than in the least affected nails (P < 0.005). CONCLUSION: A high rate of concomitant fungal infections, especially yeasts and NDMs, was found in psoriatic nail patients. The rate of isolation of fungal species was higher in severely involved psoriatic nails than mildly involved ones. The spectrum of fungal species isolated from the the severely involved toenails and fingernails were also different from each other. These organisms may be true pathogens that cause onychomycosis or their presence may reflect colonization, contamination, or concurrent infection.

SELECTION OF CITATIONS
SEARCH DETAIL
...